Steady-Eddie Stocks at Good Prices
We screen for low risk/high reward stocks.
We screen for low risk/high reward stocks.
Oftentimes it is the high risk/high reward stocks that are the most talked about. Will BP (BP) be able to survive the Gulf Oil disaster? Will a biotech's novel new drug get approved? Will a tech firm's new product be the next big thing?
But what about low risk/high reward stocks? These are companies that might not be making headlines every day but that have steady, predictable businesses and that have become cheap for one reason or another. Oftentimes the marketplace believes the risks surrounding the company are greater than they actually are, or the firms are getting painted with a broad brush
To find these low risk/high reward stocks, we used Morningstar's Premium Stock Screener. We looked for stocks that have a low fair value uncertainty rating, a narrow or wide economic moat, and that have a 5-star rating. To see the complete list, run the screen for yourself here.
Many of the firms that passed are large pharmaceutical firms like Abbott Labs (ABT) and Johnson & Johnson (JNJ) that sold off over health-care reform fears, among other issues. But our analysts think that these concerns are largely overblown, and that these firms will be able to solider on producing piles of cash that can be reinvested or returned to shareholders.
Of course no stock is without risk, but given these companies' long-term competitive advantages and bargain valuations, investors would be well served to see if they have a place in their portfolios.
Here's a closer look at a few names that passed the screen.
Procter & Gamble (PG)
Moat: Wide | Projected Dividend Yield: 3.15%
From the Premium Analyst Report:
Procter & Gamble's size confers tremendous benefits in terms of distribution, brand reach, and scale with suppliers, but the goliath was caught flat-footed in its response to the dramatic downturn in consumer spending. With a new CEO at the helm, however, P&G has implemented plans to reinvigorate top-line and earnings growth, and we remain confident that the household products stalwart will be able to reposition itself for a more challenging economy. At its core, P&G possesses unprecedented skills in consumer understanding, marketing, and brand-building and--the firm's slow reaction to the downturn notwithstanding--these skills haven't wavered.
Spectra Energy Corporation
Moat: Wide | Projected Dividend Yield: 4.69%
From the Premium Analyst Report:
Spectra Energy is a pure play on natural gas demand. Its operations stretch across all links in the natural gas value chain, with the exception of riskier exploration and production. With large positions in gathering and processing, transportation and storage, and distribution, Spectra collects a large portion of economic rents paid to get gas to end users.
Becton, Dickinson and Company (BDX)
Moat: Narrow | Projected Dividend Yield: 2.05%
From the Premium Analyst Report:
Becton, Dickinson's needle and surgical tool empire has provided investors with robust returns on capital for years. Now, largely because of the company's decades-long dedication to innovation and wise deployment of capital, its business is prospering and its investors remain amply rewarded even in this challenging economic environment.
All data as of 6/17/10
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.